Results 171 to 180 of about 50,217 (224)

Evaluation of the clinical utility of medical tests in chronic urticaria. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Sánchez J, Caraballo AL, García E.
europepmc   +1 more source

Dermographometer assessment in children with urticaria. [PDF]

open access: yesWorld Allergy Organ J
Suksai P   +5 more
europepmc   +1 more source

Do consumers and healthcare professionals report the same adverse event differently? A paired analysis of duplicate vaccine safety reports in Norway

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3559-3575, October 2026.
Aim This study aimed to compare how Norwegian healthcare professionals (HCPs) and consumers reported the same adverse event (AE) following immunization with vaccines against COVID‐19 during the COVID‐19 pandemic. Specifically, we aimed to compare the extent to which HCPs and consumers reported information relevant for assessing the causal relationship ...
Tommy Emil Dzus   +4 more
wiley   +1 more source

Experiences From the First Year of Using Garadacimab to Treat Hereditary Angioedema and Acquired Angioedema

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Background Garadacimab, a first‐in‐class, recombinant monoclonal antibody targeting activated FXII, is available in Germany for long‐term prophylaxis (LTP) of hereditary angioedema (HAE) since March 2025. We aimed to examine garadacimab real‐life treatment outcomes at our Berlin Angioedema Center of Reference and Excellence (ACARE), the ...
Markus Magerl   +5 more
wiley   +1 more source

Sesame Immunotherapy: A Systematic Review and Narrative Synthesis

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Sesame allergy is associated with severe allergic reactions, low rates of spontaneous resolution, and significant psychosocial burden. Current management relies on strict avoidance and emergency treatment. Allergen‐specific immunotherapy, particularly oral immunotherapy (OIT), has emerged as a potential disease‐modifying approach, but evidence
Joanna Zielińska   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy